ArticleCurrent computer-aided drug design2025

Comprehensive Analysis and Experimental Validation of FOXD2 as a Novel Potential Prognostic Biomarker Associated with Immune Infiltration in Head and Neck Squamous Cell Carcinoma.

Hanping He et al.PubMed ↗Publisher ↗

No numbers read from the abstract.